In transfusion dependent thalassemia major patients, HBV infection is common, thus immunization against HBV will reduce and prevent the rate of infection.In this study we want to evaluate the anti-HBs titer after vaccination. This trail was done on 217 patients, 18.4% of patients had no response, 23% had low response and 58.5% had normal response to anti-HBV vaccination. Except the duration of vaccination, we did not fine any relation between age, splenectomy, chelation therapy, transfusion, serum ferritin level and anti-HBs titer.There were also 26 patients with positive HBc-Ab, among these patients, 42.31% was not detectable.Although we found acceptable anti-HBs titers after vaccination, but because of low incidence of HBV infection and high cost of producing the vaccine, and no response to booster, it seems that revaccination is unnecessary.